Life is full of negative events that threaten our self-worth, and we deploy a wide range of potent psychological strategies-such as dissonance reduction, motivated reasoning, downward comparison, self-serving attribution, and outgroup derogation-to defend our egos. People are highly adept at using these psychological immune system strategies while remaining blind to the fact that they have done so. In fact, prominent voices in the field have suggested that this lack of awareness is a necessary condition for the psychological immune system's efficacy; how else could someone continue to believe a self-serving attribution while being aware that the attribution was generated precisely because it favored him or her? In this article, I outline the argument underlying why awareness might be a threat to the efficacy of the psychological immune system and then closely review the empirical literature for evidence supporting this claim. On the contrary, the data indicate people can and do use these strategies with awareness, intention, and efficacy. I subsequently consider three ways people may achieve the apparent paradox of being aware of their own biased mental processes while also believing the conclusions that result from them. The third of these is a novel conceptual approach to the illusion of objectivity, which highlights the potential for dissociation between the objectivity of our mental processes and of our mental products. Finally, I outline the implications of this work for future theoretical and applied research.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/1745691615621280 | DOI Listing |
Rheumatol Adv Pract
December 2024
Rheumatology Department, King's College Hospital, London, UK.
Objectives: Physical function in RA is largely influenced by multiple clinical factors, however, there is a growing body of evidence that psychological state and other comorbidities also play an essential role. Using data obtained in the COVID-19 Vaccination in Autoimmune Diseases study, an international self-reported e-survey, we aimed to explore the predictive ability of sociodemographic and clinical variables on Patient-Reported Outcomes Measurement Information System Physical Function Short Form 10a (PROMIS PF-10a) in RA and to investigate variation in disease activity and functional outcomes based on country-level socio-economic parameters.
Methods: Patient demographics, disease characteristics including current symptom status, functional status and treatment variables, as well as income level of the country of residence, were extracted from survey responses.
Adv Rheumatol
January 2025
Department of Rheumatology, Hospital de Clínicas de Porto Alegre/Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
Objectives: To compare the impact of COVID-19 on the clinical status and psychological distress of patients with immune-mediated rheumatic disease (IMRD) caused by SARS-CoV-2 infection with that of noninfected IMRD controls during a 6-month follow-up period.
Methods: The ReumaCoV Brazil is a longitudinal study designed to follow IMRD patients for 6 months after COVID-19 (patients) compared with IMRD patients without COVID-19 (controls). Clinical data, disease activity measurements and current treatments regarding IMRD and COVID-19 outcomes were evaluated in all patients.
Objective: In today's fast-paced society, stress has become a widespread phenomenon, garnering increasing attention for its impact on cancer. This study aims to investigate the current status and research hotspots of chronic stress in cancer research from 2014 to 2024, with the goal of providing valuable insights for future studies.
Methods: We retrieved 618 articles published between 2014 and 2024 from the Web of Science database and analyzed them using R software, VOSviewer, and CiteSpace.
BMJ Open
January 2025
Collaborative Drug Discovery Research (CDDR) Group, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Bandar Puncak Alam, Malaysia.
Introduction: Yeast beta-glucan (YBG) are recognised for enhancing the immune system by activating macrophages, a key defence mechanism. Given the global prevalence and impact of upper respiratory tract infections (URTIs) on productivity and healthcare costs, YBG has shown promise as a potential therapeutic and preventive strategy for recurrent respiratory tract infections. However, little is known regarding the efficacy of YBG at lower dosages in relation to URTI, fatigue, immune response and uncertainties of how they affect the gut microbiota composition.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!